Lexicon Pharmaceuticals, Inc. Share Price Today: Live Updates & Key Insights
Lexicon Pharmaceuticals, Inc. share price today is $1.565, up -3.7%. The stock opened at $1.59 against the previous close of $1.62, with an intraday high of $1.595 and low of $1.515.
Lexicon Pharmaceuticals, Inc. Share Price Chart
Lexicon Pharmaceuticals, Inc.
Lexicon Pharmaceuticals, Inc. Share Price Performance
Lexicon Pharmaceuticals, Inc. Institutional Holdings
Lexicon Pharmaceuticals, Inc. Market Status
Lexicon Pharmaceuticals, Inc. Fundamentals
Market Cap 660.94 M
PB Ratio 6.1658
PE Ratio 0.0
Enterprise Value 629.65 M
Total Assets 184.99 M
Volume 6680626
Lexicon Pharmaceuticals, Inc. Company Financials
About Lexicon Pharmaceuticals, Inc. & investment objective
Company Information Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products for the treatment of human disease. The company develops sotagliflozin, an orally-delivered small molecule drug for the treatment of hypertrophic cardiomyopathy, and ZYNQUISTA (sotagliflozin) for the treatment of type 1 diabetes. It also commercializes INPEFA (sotagliflozin), a once-daily oral tablet to reduce the risk of cardiovascular death, hospitalization for heart failure, and urgent heart failure visit in adults with heart failure or type 2 diabetes, CKD, and other cardiovascular risk factors. In addition, the company develops LX9851, an orally-delivered small molecule drug candidate for the treatment of obesity and associated cardiometabolic disorders, and pilavapadin (LX9211), an orally-delivered small molecule drug candidate for the treatment of neuropathic pain. It has strategic collaboration and license agreements with Viatris Inc. and Bristol-Myers Squibb Company. The company was incorporated in 1995 and is headquartered in The Woodlands, Texas.
Organisation Biotechnology
Employees 81
Industry Biotechnology
CEO null
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
Lexicon Pharmaceuticals, Inc. FAQs
What is the share price of Lexicon Pharmaceuticals, Inc. today?
The current share price of Lexicon Pharmaceuticals, Inc. is $1.565.
Can I buy Lexicon Pharmaceuticals, Inc. shares in India?
Yes, Indian investors can buy Lexicon Pharmaceuticals, Inc. shares by opening an international trading and demat account with Motilal Oswal.
How to buy Lexicon Pharmaceuticals, Inc. shares in India?
You can easily invest in Lexicon Pharmaceuticals, Inc. shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy Lexicon Pharmaceuticals, Inc. shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of Lexicon Pharmaceuticals, Inc..
Can I buy fractional shares of Lexicon Pharmaceuticals, Inc.?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of Lexicon Pharmaceuticals, Inc.?
Lexicon Pharmaceuticals, Inc. has a market cap of $660.94 M.
In which sector does Lexicon Pharmaceuticals, Inc. belong?
Lexicon Pharmaceuticals, Inc. operates in the Biotechnology sector.
What documents are required to invest in Lexicon Pharmaceuticals, Inc. stocks?
To invest, you typically need:
What is the PE and PB ratio of Lexicon Pharmaceuticals, Inc.?
The PE ratio of Lexicon Pharmaceuticals, Inc. is N/A and the PB ratio is 6.17.